A carregar...
BCAP31 drives TNBC development by modulating ligand-independent EGFR trafficking and spontaneous EGFR phosphorylation
Identification of novel targets for triple-negative breast cancer (TNBC) is an urgent task as targeted therapies have increased the lifespans of Oestrogen Receptor (+)/ Progesterone Receptor (+) and HER(2+) cancer patients. Methods: genes involved in protein processing in the endoplasmic reticulum,...
Na minha lista:
| Publicado no: | Theranostics |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6771250/ https://ncbi.nlm.nih.gov/pubmed/31588230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.35383 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|